SEC 13F Intelligence

Vida Ventures Advisors, LLC / DYN

Vida Ventures Advisors, LLC’s Dyne Therapeutics Inc Position

Does Vida Ventures Advisors, LLC own Dyne Therapeutics Inc (DYN)? Not currently — the last reported position was 407.5K shares worth $10M in Q4 2024; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$10M
Q4 2024
Shares
407.5K
% of Portfolio
+6.56%
Quarters Held
18
position exited

Position History DYN

Reported value by quarter
Q3 ’20: $60MQ3 ’20Q4 ’20: $62MQ1 ’21: $46MQ2 ’21: $62MQ2 ’21Q3 ’21: $48MQ4 ’21: $35MQ1 ’22: $29MQ1 ’22Q2 ’22: $20MQ3 ’22: $28MQ4 ’22: $26MQ4 ’22Q1 ’23: $26MQ2 ’23: $25MQ3 ’23: $20MQ3 ’23Q4 ’23: $28MQ1 ’24: $12MQ2 ’24: $14MQ2 ’24Q3 ’24: $15MQ4 ’24: $10Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 2024407.5K$10M+6.56%
Q3 2024407.5K$15M+10.56%
Q2 2024407.5K$14M+15.73%
Q1 2024407.5K$12M+6.43%
Q4 20232.07M$28M+32.85%
Q3 20232.22M$20M+30.79%
Q2 20232.22M$25M+32.61%
Q1 20232.22M$26M+34.99%
Q4 20222.22M$26M+34.58%
Q3 20222.22M$28M+25.30%
Q2 20222.96M$20M+17.18%
Q1 20222.96M$29M+16.60%
Q4 20212.96M$35M+13.17%
Q3 20212.96M$48M+13.77%
Q2 20212.96M$62M+15.62%
Q1 20212.96M$46M+11.61%
Q4 20202.96M$62M+12.76%
Q3 20202.96M$60M+37.43%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vida Ventures Advisors, LLC’s full portfolio or all institutional holders of DYN.